Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Rezza

Showing results (21-30 of 241) with videos related to

Pageof 25
Sort By:
AIDS (London, England)|October 1, 1988
Significance of HIV antibody testing as a preventive measure in intravenous drug usersH Sasse, S Salmaso, S Conti, et al.
British Journal of Addiction|September 1, 1991
Sexual lifestyles in injecting drug users in Italy: potential for HIV infection transmission. First Multicentre Study GroupH Sasse, S Salmaso, S Conti, et al.
Infection|April 14, 2005
Temporal trend in the level of 90K glycoprotein after HIV seroconversion among persons coinfected with hepatitis C virusM Dorrucci, M Ciccozzi, S Iacobelli, et al.
American Journal of Public Health|March 1, 1997
HIV/AIDS surveillance in Italy: the potential misinterpretation of time trendsP Pezzotti, C Piovesan, G Rezza, et al.
Lancet (London, England)|September 15, 1984
AIDS in ItalyG Rezza, G Ippolito, G Marasca, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|December 11, 2012
Probable autochthonous introduced malaria cases in Italy in 2009-2011 and the risk of local vector-borne transmissionR Romi, D Boccolini, M Menegon, et al.
Nature|July 5, 1987
Italian HIV infection updatedG Luzi, F Aiuti, G Rezza, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 24, 2001
Different pattern of AIDS-defining diseases in persons responding to highly active antiretroviral therapyT M Wagner, P Pezzotti, C Valdarchi, et al.
The Journal of Infection|January 1, 1993
IgA as a marker of clinical progression among HIV-seropositive intravenous drug usersS Gafà, M G Giudici, P Pezzotti, et al.
The Journal of Infection|May 1, 1995
Evaluation of symptoms suggestive of HIV acute disease among injecting drug usersG Rezza, M Dorrucci, P Pezzotti, et al.
Pageof 25

Showing results (21-30 of 241) with videos related to

Sort By:
Pageof 25
AIDS (London, England)|October 1, 1988
Significance of HIV antibody testing as a preventive measure in intravenous drug usersH Sasse, S Salmaso, S Conti, et al.
British Journal of Addiction|September 1, 1991
Sexual lifestyles in injecting drug users in Italy: potential for HIV infection transmission. First Multicentre Study GroupH Sasse, S Salmaso, S Conti, et al.
Infection|April 14, 2005
Temporal trend in the level of 90K glycoprotein after HIV seroconversion among persons coinfected with hepatitis C virusM Dorrucci, M Ciccozzi, S Iacobelli, et al.
American Journal of Public Health|March 1, 1997
HIV/AIDS surveillance in Italy: the potential misinterpretation of time trendsP Pezzotti, C Piovesan, G Rezza, et al.
Lancet (London, England)|September 15, 1984
AIDS in ItalyG Rezza, G Ippolito, G Marasca, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|December 11, 2012
Probable autochthonous introduced malaria cases in Italy in 2009-2011 and the risk of local vector-borne transmissionR Romi, D Boccolini, M Menegon, et al.
Nature|July 5, 1987
Italian HIV infection updatedG Luzi, F Aiuti, G Rezza, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 24, 2001
Different pattern of AIDS-defining diseases in persons responding to highly active antiretroviral therapyT M Wagner, P Pezzotti, C Valdarchi, et al.
The Journal of Infection|January 1, 1993
IgA as a marker of clinical progression among HIV-seropositive intravenous drug usersS Gafà, M G Giudici, P Pezzotti, et al.
The Journal of Infection|May 1, 1995
Evaluation of symptoms suggestive of HIV acute disease among injecting drug usersG Rezza, M Dorrucci, P Pezzotti, et al.
Pageof 25